Related Experiment Video
Updated: Feb 13, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
[Current status of development for regenerative cell therapy, SB623]
1SanBio Co., Ltd.
SB623 cell transplantation shows promise for chronic ischemic stroke repair. This regenerative medicine approach demonstrated safety and significant clinical improvements in a Phase I/IIa study.
Area of Science:
- Regenerative Medicine
- Neuroscience
- Clinical Neurology
Background:
- Chronic ischemic stroke leads to significant brain damage.
- Current treatments for chronic stroke have limited efficacy.
- SB623 is an investigational regenerative medicine product.
Purpose of the Study:
- To evaluate the safety and clinical outcomes of SB623 cell transplantation in patients with chronic ischemic stroke.
- To assess the potential of SB623 to promote brain repair after stroke.
Main Methods:
- An open-label, single-arm Phase I/IIa clinical study was conducted.
- 18 patients with chronic ischemic stroke were enrolled in the United States.
- Surgical transplantation of SB623 was performed, followed by a one-year follow-up period.
Main Results:
- Significant improvements were observed in mean scores across the European Stroke Scale, National Institutes of Health Stroke Scale, and Fugl-Meyer Assessment.
- No side effects or serious treatment-emergent adverse events related to SB623 cell transplantation were reported.
- SB623 demonstrated a favorable safety profile and potential efficacy in improving functional outcomes.
Conclusions:
- SB623 cell transplantation is a safe and effective therapeutic option for chronic ischemic stroke.
- Regenerative medicine with SB623 holds potential for brain repair.
- Ongoing clinical studies in Japan and the US aim to accelerate development and patient access.
More Related Videos
11:02Establishing Organoids from Human Tooth as a Powerful Tool Toward Mechanistic Research and Regenerative Therapy
Published on: April 13, 2022
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Related Concept Videos
Marcia's Theory of Identity Status
Gene Therapy
Electrical Current
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Sustainable Development
Group Therapy